遺伝子毒性検査の世界市場レポート 2025年

遺伝子毒性検査の市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は10.0％で、26億4,000万米ドルに成長します。予測期間の成長は、新規食品の試験需要の高まり、潜在的リスクに対する懸念の高まり、環境および健康に対する懸念の高まり、規制当局の監視の強化、in vitro試験法の使用の増加、ハイスループットスクリーニングプラットフォームの台頭などに起因すると考えられます。予測期間における主な動向には、精密医療とトキシコゲノミクスの進歩、包括的リスクコミュニケーション、遺伝子毒性検査手法、リスク評価手法の進歩、オミックス技術の統合、ゲノムと分子生物学の進歩などがあります。

個別化医療に対する需要の急増は、今後数年間の遺伝子毒性検査市場の拡大を促進すると予想されます。個別化医療は、予測される反応や疾患リスクに基づいて個々の患者に合わせた介入や製品を提供するヘルスケアアプローチであり、遺伝子の進歩、疾患理解の向上、バイオマーカーに基づく診断の利用可能性、価値に基づくヘルスケアへの取り組み、臨床診療や研究への統合によって支持を集めています。遺伝子毒性検査は、遺伝子の多様性、遺伝毒性物質に対する感受性、治療反応に関する重要な洞察を提供することにより、個別化医療において重要な役割を果たしています。例えば、2024年2月に個別化医療連合（Personalized Medicine Coalition）が報告したように、FDAは2023年に希少疾患患者向けに16の個別化新薬を認可し、2022年の6から大幅に増加しました。このように、個別化医療に対する需要の高まりは、遺伝子毒性検査市場の起爆剤となっています。

遺伝子毒性検査市場の主要企業は、潜在的な遺伝子毒素を特定する精度と効率を高めるため、表現型薬剤スクリーニングなどの革新的な薬剤スクリーニング・プラットフォームの開発に注力しています。表現型薬物スクリーニングでは、全生物または関連する細胞系における特定の細胞反応または生理学的反応を誘発する能力に基づいて化合物を試験します。例えば、2022年8月、米国のバイオテクノロジー企業であるCreative Biogene社は、創薬や毒物学研究をサポートするために調整されたゼブラフィッシュ疾患モデルを発表しました。これらのモデルはヒトの遺伝性疾患をゼブラフィッシュで再現し、疾患メカニズム、創薬、毒性学に関する洞察を提供します。クリエイティブ・バイオジーン社のゼブラフィッシュ・モデルは、薬物毒性の評価、新規化合物の安全性の予測、医薬品開発パイプラインの強化に役立つ貴重なツールです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界遺伝子毒性検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝子毒性検査市場：成長率分析
• 世界の遺伝子毒性検査市場の実績：規模と成長, 2019-2024
• 世界の遺伝子毒性検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界遺伝子毒性検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子毒性検査市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• In vitro（体外）
• In vivo
• 世界の遺伝子毒性検査市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• サービス
• 試薬および消耗品
• アッセイ
• 世界の遺伝子毒性検査市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヘルスケア業界
• 食品業界
• 化粧品業界
• 農業産業
• その他の用途
• 世界の遺伝子毒性検査市場、in vitroのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エイムズテスト
• 微小核試験
• コメットアッセイ
• 染色体異常検査
• 細胞形質転換アッセイ
• その他の体外試験法
• 世界の遺伝子毒性検査市場、生体内サブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 微小核試験（げっ歯類）
• コメットアッセイ（生体内）
• 骨髄染色体異常検査
• 優性致死試験（げっ歯類）
• その他の生体内方法

第7章 地域別・国別分析

• 世界の遺伝子毒性検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の遺伝子毒性検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子毒性検査市場：競合情勢
• 遺伝子毒性検査市場：企業プロファイル
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Quest Diagnostics Incorporated
• Eurofins Scientific SE
• SGS SA
• WuXi AppTec
• Intertek Group plc
• Charles River Laboratories International Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Fraunhofer ITEM
• Jubilant Life Sciences Limited
• Evotec SE
• Inotiv Inc.
• Promega Corporation
• Syngene International Limited
• Nelson Laboratories LLC

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子毒性検査市場2029：新たな機会を提供する国
• 遺伝子毒性検査市場2029：新たな機会を提供するセグメント
• 遺伝子毒性検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Genetic toxicology testing is a specialized field within toxicology dedicated to assessing the potential of chemical substances to cause damage to genetic material, including DNA, RNA, and chromosomes. Its primary objective is to determine the genotoxicity of compounds and identify any adverse effects they may have on the genetic material of living organisms, including humans. This testing serves as a crucial tool for evaluating the safety of pharmaceuticals, chemicals, and environmental pollutants, particularly concerning genotoxic hazards.

The primary classifications within the genetic toxicology testing market include in vitro and in vivo methodologies. In vitro testing refers to experiments or studies conducted in a controlled laboratory environment, such as test tubes, petri dishes, or other artificial settings, without the involvement of living organisms. Various products encompass services, reagents, consumables, and assays, utilized across diverse applications spanning the healthcare, food, cosmetics, agriculture industries, among others.

The genetic toxicology testing market research report is one of a series of new reports from The Business Research Company that provides genetic toxicology testing market statistics, including the genetic toxicology testing industry's global market size, regional shares, competitors with a genetic toxicology testing market share, detailed genetic toxicology testing market segments, market trends, and opportunities, and any further data you may need to thrive in the genetic toxicology testing industry. This genetic toxicology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genetic toxicology testing market size has grown rapidly in recent years. It will grow from $1.63 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising public health crises, increasing globalization, increased focus on personalized medicine, rising demand for rigorous testing solutions, and an increasing number of drugs.

The genetic toxicology testing market size is expected to see rapid growth in the next few years. It will grow to $2.64 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to rising demand for testing novel foods, rising concerns about potential risks, rising environmental and health concerns, increasing regulatory scrutiny, increasing use of in vitro testing methods, and the rise of high-throughput screening platforms. Major trends in the forecast period include advances in precision medicine and toxicogenomic, comprehensive risk communication, genetic toxicology testing methodologies, advancing risk assessment methodologies, integration of omics technologies, and advancements in genomics and molecular biology.

The surge in demand for personalized medicine is anticipated to drive the expansion of the genetic toxicology testing market in the coming years. Personalized medicine, a healthcare approach that tailors interventions and products to individual patients based on their predicted response or disease risk, has gained traction due to genetic advancements, improved disease understanding, biomarker-based diagnostics availability, value-based healthcare initiatives, and integration into clinical practice and research. Genetic toxicology testing plays a vital role in personalized medicine by furnishing crucial insights into genetic variability, susceptibility to genotoxic agents, and treatment response. For instance, as reported by the Personalized Medicine Coalition in February 2024, the FDA greenlit 16 new personalized medicines for rare disease patients in 2023, a significant increase from six in 2022. Thus, the growing demand for personalized medicine serves as a catalyst for the genetic toxicology testing market.

Major players in the genetic toxicology testing market are concentrating on developing innovative drug screening platforms such as phenotypic drug screening to enhance accuracy and efficiency in identifying potential genetic toxins. Phenotypic drug screening involves testing compounds based on their capacity to elicit a specific cellular or physiological response in a whole organism or relevant cell system. For example, in August 2022, Creative Biogene, a US-based biotechnology company, unveiled zebrafish disease models tailored to support drug discovery and toxicology research. These models replicate human genetic diseases in zebrafish, offering insights into disease mechanisms, drug discovery, and toxicology. Creative Biogene's zebrafish models serve as a valuable tool for evaluating drug toxicity, predicting the safety of novel compounds, and bolstering the drug development pipeline.

In September 2024, Scantox Group, a Denmark-based contract research organization, acquired Gentronix for an undisclosed amount. This acquisition enables Scantox to enhance its portfolio by incorporating Gentronix's expertise in genetic toxicology testing. Gentronix Ltd., a UK-based company, specializes in providing accurate genetic toxicology testing services.

Major companies operating in the genetic toxicology testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, SGS SA, WuXi AppTec, Intertek Group plc, Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Fraunhofer ITEM, Jubilant Life Sciences Limited, Evotec SE, Inotiv Inc., Promega Corporation, Syngene International Limited, Nelson Laboratories LLC, Instem, Frontage Laboratories Inc., Creative Bioarray, Creative Biolabs Inc., Gentronix Limited, MB Research Laboratories.

North America was the largest region in the genetic toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genetic toxicology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genetic toxicology testing market includes revenues earned by entities through mutagenicity testing, genotoxicity screening, carcinogenicity testing, regulatory compliance, risk assessment, bacterial mutation assays, comet assays, micronucleus tests, presymptomatic testing, ancestry testing, and nutrigenomics testing, and related cell culture systems, assay kits, microscopes, flow cytometers, automation and robotics, and flow cytometry. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Toxicology Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on genetic toxicology testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genetic toxicology testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The genetic toxicology testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: In Vitro; In Vivo
• 2) By Product: Services; Reagents And Consumables; Assays
• 3) By Application: Healthcare Industry; Food Industry; Cosmetics Industry; Agriculture Industry; Other Applications
• Subsegments:
• 1) By In Vitro: Ames Test; Micronucleus Assay; Comet Assay; Chromosomal Aberration Test; Cell Transformation Assay; Other In Vitro Methods
• 2) By In Vivo: Micronucleus Test (Rodent); Comet Assay (In Vivo); Bone Marrow Chromosomal Aberration Test; Dominant Lethal Test (Rodent); Other In Vivo Methods
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Merck KGaA; Laboratory Corporation of America Holdings
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Genetic Toxicology Testing Market Characteristics

3. Genetic Toxicology Testing Market Trends And Strategies

4. Genetic Toxicology Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Genetic Toxicology Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Genetic Toxicology Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Genetic Toxicology Testing Market Growth Rate Analysis
• 5.4. Global Genetic Toxicology Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Genetic Toxicology Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Genetic Toxicology Testing Total Addressable Market (TAM)

6. Genetic Toxicology Testing Market Segmentation

• 6.1. Global Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• In Vitro
• In Vivo
• 6.2. Global Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Services
• Reagents And Consumables
• Assays
• 6.3. Global Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Healthcare Industry
• Food Industry
• Cosmetics Industry
• Agriculture Industry
• Other Applications
• 6.4. Global Genetic Toxicology Testing Market, Sub-Segmentation Of In Vitro, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ames Test
• Micronucleus Assay
• Comet Assay
• Chromosomal Aberration Test
• Cell Transformation Assay
• Other In Vitro Methods
• 6.5. Global Genetic Toxicology Testing Market, Sub-Segmentation Of In Vivo, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Micronucleus Test (Rodent)
• Comet Assay (In Vivo)
• Bone Marrow Chromosomal Aberration Test
• Dominant Lethal Test (Rodent)
• Other In Vivo Methods

7. Genetic Toxicology Testing Market Regional And Country Analysis

• 7.1. Global Genetic Toxicology Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Genetic Toxicology Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Genetic Toxicology Testing Market

• 8.1. Asia-Pacific Genetic Toxicology Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Genetic Toxicology Testing Market

• 9.1. China Genetic Toxicology Testing Market Overview
• 9.2. China Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Genetic Toxicology Testing Market

• 10.1. India Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Genetic Toxicology Testing Market

• 11.1. Japan Genetic Toxicology Testing Market Overview
• 11.2. Japan Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Genetic Toxicology Testing Market

• 12.1. Australia Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Genetic Toxicology Testing Market

• 13.1. Indonesia Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Genetic Toxicology Testing Market

• 14.1. South Korea Genetic Toxicology Testing Market Overview
• 14.2. South Korea Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Genetic Toxicology Testing Market

• 15.1. Western Europe Genetic Toxicology Testing Market Overview
• 15.2. Western Europe Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Genetic Toxicology Testing Market

• 16.1. UK Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Genetic Toxicology Testing Market

• 17.1. Germany Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Genetic Toxicology Testing Market

• 18.1. France Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Genetic Toxicology Testing Market

• 19.1. Italy Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Genetic Toxicology Testing Market

• 20.1. Spain Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Genetic Toxicology Testing Market

• 21.1. Eastern Europe Genetic Toxicology Testing Market Overview
• 21.2. Eastern Europe Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Genetic Toxicology Testing Market

• 22.1. Russia Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Genetic Toxicology Testing Market

• 23.1. North America Genetic Toxicology Testing Market Overview
• 23.2. North America Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Genetic Toxicology Testing Market

• 24.1. USA Genetic Toxicology Testing Market Overview
• 24.2. USA Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Genetic Toxicology Testing Market

• 25.1. Canada Genetic Toxicology Testing Market Overview
• 25.2. Canada Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Genetic Toxicology Testing Market

• 26.1. South America Genetic Toxicology Testing Market Overview
• 26.2. South America Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Genetic Toxicology Testing Market

• 27.1. Brazil Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Genetic Toxicology Testing Market

• 28.1. Middle East Genetic Toxicology Testing Market Overview
• 28.2. Middle East Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Genetic Toxicology Testing Market

• 29.1. Africa Genetic Toxicology Testing Market Overview
• 29.2. Africa Genetic Toxicology Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Genetic Toxicology Testing Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Genetic Toxicology Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Genetic Toxicology Testing Market Competitive Landscape And Company Profiles

• 30.1. Genetic Toxicology Testing Market Competitive Landscape
• 30.2. Genetic Toxicology Testing Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

31. Genetic Toxicology Testing Market Other Major And Innovative Companies

• 31.1. Quest Diagnostics Incorporated
• 31.2. Eurofins Scientific SE
• 31.3. SGS SA
• 31.4. WuXi AppTec
• 31.5. Intertek Group plc
• 31.6. Charles River Laboratories International Inc.
• 31.7. PerkinElmer Inc.
• 31.8. Bio-Rad Laboratories Inc.
• 31.9. Fraunhofer ITEM
• 31.10. Jubilant Life Sciences Limited
• 31.11. Evotec SE
• 31.12. Inotiv Inc.
• 31.13. Promega Corporation
• 31.14. Syngene International Limited
• 31.15. Nelson Laboratories LLC

32. Global Genetic Toxicology Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Genetic Toxicology Testing Market

34. Recent Developments In The Genetic Toxicology Testing Market

35. Genetic Toxicology Testing Market High Potential Countries, Segments and Strategies

• 35.1 Genetic Toxicology Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Genetic Toxicology Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Genetic Toxicology Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer